A Novel Co-Drug of Aspirin and Ursolic Acid Interrupts Adhesion, Invasion and Migration of Cancer Cells to Vascular Endothelium via Regulating EMT and EGFR-mediated Signaling Pathways: Multiple Targets for Cancer Metastasis Prevention and Treatment

Oncotarget - United States
doi 10.18632/oncotarget.12232
Full Text
Abstract

Available in full text

Categories
Oncology
Date
Authors
Publisher

Impact Journals, LLC

Related search

Molecular Pathways: Aspirin and WNT Signaling--A Molecularly Targeted Approach to Cancer Prevention and Treatment

Clinical Cancer Research
Cancer ResearchOncology
2014English

Lysophosphatidic Acid Targets Vascular and Oncogenic Pathways via RAGE Signaling

Journal of Experimental Medicine
MedicineAllergyImmunology
2012English

SKA2 Mediates Invasion and Metastasis in Human Breast Cancer via EMT

Molecular Medicine Reports
OncologyGeneticsMolecular BiologyBiochemistryCancer ResearchMolecular Medicine
2018English

The Role of Cyclic Nucleotide Signaling Pathways in Cancer: Targets for Prevention and Treatment

Cancers
Cancer ResearchOncology
2014English

Molecular Targets of Aspirin and Cancer Prevention

British Journal of Cancer
Cancer ResearchOncology
2014English

Scutellaria?barbata D. Don Inhibits Migration and Invasion of Colorectal Cancer Cells via Suppression of PI3K/AKT and TGF‑β/Smad Signaling Pathways

Experimental and Therapeutic Medicine
MedicineCancer ResearchImmunologyMicrobiology
2017English

A Novel Sialyltransferase Inhibitor Suppresses FAK/Paxillin Signaling and Cancer Angiogenesis and Metastasis Pathways

Cancer Research
Cancer ResearchOncology
2011English

RRM2 Elicits the Metastatic Potential of Breast Cancer Cells by Regulating Cell Invasion, Migration and VEGF Expression via the PI3K/AKT Signaling

Oncology Letters
Cancer ResearchOncology
2020English

C4orf7 Contributes to Ovarian Cancer Metastasis by Promoting Cancer Cell Migration and Invasion

Oncology Reports
MedicineCancer ResearchOncology
2010English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy